Q4 2021 Holdings
Filed 2022-02-15 | 73 holdings | $62.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $21.7M | 128,000 | 34.8% |
| Biogen Inc(BIIB) | COM | 09062X103 | $11.4M | 47,500 | 18.3% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $9.3M | 105,156 | 14.9% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $7.6M | 334,500 | 12.3% |
| Beigene LTD(ONC) | Sponsored ADR | 07725L102 | $5.4M | 20,000 | 8.7% |
| Ascendis Pharma AS(ASND) | Sponsored ADR | 04351P101 | $4.0M | 29,400 | 6.3% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $881.0K | 52,800 | 1.4% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $747.0K | 50,000 | 1.2% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $707.0K | 21,500 | 1.1% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $235.0K | 44,000 | 0.4% |
| Amgen Inc(AMGN) | COM | 031162100 | $32.6K | 144,746 | 0.1% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $23.8K | 280,000 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $20.9K | 285,000 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $20.5K | 282,784 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $19.3K | 139,900 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $18.5K | 126,500 | 0.0% |
| PTC Therapuetics COM(PTCT) | COM | 69366J200 | $17.9K | 449,000 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $17.5K | 113,200 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $17.0K | 77,222 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $14.3K | 37,500 | 0.0% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $11.8K | 380,000 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $11.6K | 138,100 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $10.8K | 355,088 | 0.0% |
| Horizon Therapeutics PUB LTD | SHS | G4617B105 | $10.8K | 99,873 | 0.0% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $10.1K | 236,000 | 0.0% |
| Exelixis Inc(EXC) | COM | 30161N101 | $10.0K | 546,534 | 0.0% |
| Supernus Pharmaceuticals Inc(SUPN) | COM | 868459108 | $8.7K | 297,500 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $8.2K | 108,200 | 0.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $7.6K | 12,100 | 0.0% |
| Guardant Health Inc(GH) | COM | 40131M109 | $7.5K | 74,500 | 0.0% |
| Intra Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $5.9K | 113,456 | 0.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $5.6K | 476,000 | 0.0% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $5.6K | 44,200 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $5.1K | 383,233 | 0.0% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $4.7K | 289,389 | 0.0% |
| Insmed Inc(INSM) | COM | 457669307 | $3.3K | 121,100 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $3.2K | 155,500 | 0.0% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $3.2K | 120,535 | 0.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $3.1K | 45,000 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $2.9K | 61,741 | 0.0% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $2.8K | 24,000 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $2.8K | 94,800 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $2.6K | 109,000 | 0.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $2.4K | 38,958 | 0.0% |
| Hutchmed China LTD(HCM) | SPONSORED ADS | 44842L103 | $2.4K | 68,000 | 0.0% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $2.2K | 153,000 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $2.2K | 135,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $2.1K | 19,500 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $2.1K | 139,331 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM | 040047607 | $2.0K | 21,000 | 0.0% |